LINC-DUBR Suppresses Malignant Progression of Ovarian Cancer by Downregulating miR-107 to Induce SMAC Expression

BACKGROUND: LINC-DUBR may be a potential therapeutic target in ovarian cancer (OC). The purpose of this research was to explore the impact of miR-107 on the tumorigenicity of OC and its underlying molecular mechanisms. METHODS: RT-qPCR was adopted to measure the expression of LINC-DUBR and miR-107 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Zhehui, Li, Dan, Yang, Yun, Zhang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913066/
https://www.ncbi.nlm.nih.gov/pubmed/35281523
http://dx.doi.org/10.1155/2022/4535655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913066/
https://www.ncbi.nlm.nih.gov/pubmed/35281523
http://dx.doi.org/10.1155/2022/4535655

Ejemplares similares